194 related articles for article (PubMed ID: 11271371)
1. Differential regulation of chromogranin A, chromogranin B and secretoneurin protein expression after transient forebrain ischemia in the gerbil.
Martí E; Ferrer I; Blasi J
Acta Neuropathol; 2001 Feb; 101(2):159-66. PubMed ID: 11271371
[TBL] [Abstract][Full Text] [Related]
2. Synaptic proteins in Alzheimer's disease.
Marksteiner J; Kaufmann WA; Gurka P; Humpel C
J Mol Neurosci; 2002; 18(1-2):53-63. PubMed ID: 11931350
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatment.
Marksteiner J; Weiss U; Weis C; Laslop A; Fischer-Colbrie R; Humpel C; Feldon J; Fleischhacker WW
Neuroscience; 2001; 104(2):325-33. PubMed ID: 11377837
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic processing, axonal transport and differential distribution of chromogranins A and B, and secretogranin II (secretoneurin) in rat sciatic nerve and spinal cord.
Li JY; Leitner B; Lovisetti-Scamihorn P; Winkler H; Dahlström A
Eur J Neurosci; 1999 Feb; 11(2):528-44. PubMed ID: 10051753
[TBL] [Abstract][Full Text] [Related]
5. Distribution of chromogranins A and B and secretogranin II (secretoneurin) in rat pelvic neurons and vas deferens.
Li JY; Leitner B; Winkler H; Dahlström A
Neuroscience; 1998 May; 84(1):281-94. PubMed ID: 9522381
[TBL] [Abstract][Full Text] [Related]
6. Spatial and temporal distribution of pituitary adenylate cyclase activating polypeptide in gerbil global cerebral ischemia.
Shin CM; Chung YH; Kim MJ; Cha CI
Neurosci Lett; 2001 Aug; 309(1):53-6. PubMed ID: 11489545
[TBL] [Abstract][Full Text] [Related]
7. Chromogranins in temporal lobe epilepsy.
Kandlhofer S; Hoertnagl B; Czech T; Baumgartner C; Maier H; Novak K; Sperk G
Epilepsia; 2000; 41 Suppl 6():S111-4. PubMed ID: 10999531
[TBL] [Abstract][Full Text] [Related]
8. Early induction of secretoneurin expression following kainic acid administration at convulsant doses in the rat and gerbil hippocampus.
Marti E; Blasi J; Ferrer I
Hippocampus; 2002; 12(2):174-85. PubMed ID: 12000117
[TBL] [Abstract][Full Text] [Related]
9. Comparison of alpha-synuclein immunoreactivity and protein levels in ischemic hippocampal CA1 region between adult and aged gerbils and correlation with Cu,Zn-superoxide dismutase.
Yoon DK; Hwang IK; Yoo KY; Lee YB; Lee JJ; Kim JH; Kang TC; Lee BH; Sohn HS; Won MH
Neurosci Res; 2006 Aug; 55(4):434-41. PubMed ID: 16759729
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of immunoreactivities of peptides derived from chromogranin A (GE-25) and from secretogranin II (secretoneurin) in human and bovine cerebrospinal fluid.
Kirchmair R; Benzer A; Troger J; Miller C; Marksteiner J; Saria A; Gasser RW; Hogue-Angeletti R; Fischer-Colbrie R; Winkler H
Neuroscience; 1994 Dec; 63(4):1179-87. PubMed ID: 7535395
[TBL] [Abstract][Full Text] [Related]
11. Synaptic loss reflected by secretoneurin-like immunoreactivity in the human hippocampus in Alzheimer's disease.
Kaufmann WA; Barnas U; Humpel C; Nowakowski K; DeCol C; Gurka P; Ransmayr G; Hinterhuber H; Winkler H; Marksteiner J
Eur J Neurosci; 1998 Mar; 10(3):1084-94. PubMed ID: 9753176
[TBL] [Abstract][Full Text] [Related]
12. Co-distribution patterns of chromogranin B-like immunoreactivity with chromogranin A and secretoneurin within the human brainstem.
Kato A; Kammen-Jolly K; Fischer-Colbie R; Humpel C; Schrott-Fischer A; Marksteiner J
Brain Res; 2000 Jan; 852(2):444-52. PubMed ID: 10678772
[TBL] [Abstract][Full Text] [Related]
13. Transient ischemia-induced changes of interleukin-2 and its receptor beta immunoreactivity and levels in the gerbil hippocampal CA1 region.
Hwang IK; Yoo KY; Kim DW; Lee HJ; Kang HY; Lee HY; Kang TC; Choi SY; Kim YS; Won MH
Brain Res; 2006 Aug; 1106(1):197-204. PubMed ID: 16814753
[TBL] [Abstract][Full Text] [Related]
14. Differential increases in chromogranins, but not synapsin I, in cortical neurons following spreading depression: implications for functional roles and transmitter peptide release.
Shen PJ; Gundlach AL
Eur J Neurosci; 1998 Jul; 10(7):2217-30. PubMed ID: 9749750
[TBL] [Abstract][Full Text] [Related]
15. Regulation of chromogranin biosynthesis by neurotrophic growth factors in neuroblastoma cells.
Weiss C; Winkler H; Laslop A
Neurochem Int; 2001 Jan; 38(1):43-52. PubMed ID: 10913687
[TBL] [Abstract][Full Text] [Related]
16. Changes of pyridoxal kinase expression and activity in the gerbil hippocampus following transient forebrain ischemia.
Hwang IK; Yoo KY; Kim DS; Eum WS; Park JK; Park J; Kwon OS; Kang TC; Choi SY; Won MH
Neuroscience; 2004; 128(3):511-8. PubMed ID: 15381280
[TBL] [Abstract][Full Text] [Related]
17. Ischemia-related changes in naive and mutant forms of ubiquitin and neuroprotective effects of ubiquitin in the hippocampus following experimental transient ischemic damage.
Ahn HC; Yoo KY; Hwang IK; Cho JH; Lee CH; Choi JH; Li H; Cho BR; Kim YM; Won MH
Exp Neurol; 2009 Nov; 220(1):120-32. PubMed ID: 19666022
[TBL] [Abstract][Full Text] [Related]
18. Secretoneurin in carcinoids of the appendix-immunohistochemical comparison with chromogranins A,B and secretogranin II.
Prommegger R; Obrist P; Ensinger C; Schwelberger HG; Wolf C; Fischer-Colbrie R; Mikuz G; Bodner E
Anticancer Res; 1998; 18(6A):3999-4002. PubMed ID: 9891437
[TBL] [Abstract][Full Text] [Related]
19. Stereological assessment of vulnerability of immunocytochemically identified striatal and hippocampal neurons after global cerebral ischemia in rats.
Larsson E; Lindvall O; Kokaia Z
Brain Res; 2001 Sep; 913(2):117-32. PubMed ID: 11549375
[TBL] [Abstract][Full Text] [Related]
20. Chromogranins as markers of altered hippocampal circuitry in temporal lobe epilepsy.
Pirker S; Czech T; Baumgartner C; Maier H; Novak K; Fürtinger S; Fischer-Colbrie R; Sperk G
Ann Neurol; 2001 Aug; 50(2):216-26. PubMed ID: 11506405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]